MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    DBS for a patient with KMT2B-SHANK2 related dystonia

    L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht (New York, USA)

    Objective: Describe a case of deep brain stimulation (DBS) outcome for a patient with pathogenic variants of Shank2 and KMT2B genes. Background: Prior reports have…
  • 2022 International Congress

    Brain glia activation and peripheral inflammation in Parkinson’s disease: a PET study

    SY. Liu, HW. Qiao, TB. Song, O. Barret, FW. Qiao, XL. Liu, X. Xu, YN. Cai, G. Tamagnan, V. Sossi, P. Chan (Beijing, China)

    Objective: Abnormal activation of immune system is an important pathogenesis of Parkinson's disease, but the relationship between peripheral inflammation, central glia activation and dopaminergic degeneration…
  • 2022 International Congress

    Telemedicine in speech and swallowing disorders for patients with Parkinson’s disease: Motivation and satisfaction of patients and speech language pathologists

    Y. Manor, D. Shpunt, A. Zait, A. Ezra, N. Hezi, L. Jokel, H. First, N. Karin, M. Zirler, M. Kalish, L. Raif, A. Migirov Sandrovitz, T. Gurevich1 (Tel Aviv-Yafo, Israel)

    Objective: To assess the satisfaction with telemedicine for speech and swallowing disorders among patients with PD and speech language pathologists (SLP) as well as the…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • 2022 International Congress

    A novel platform for home-based, remotely supervised, transcranial direct current stimulation treatment and assessment for Cerebellar ataxia: A randomized, double-blind, sham-controlled, crossover, feasibility study

    N. Inbar, M. Abo-Said, P. Ponger, S. Frenkel-Toledo, M. Brozgol, Z. Hausdorff, Z. Yekutieli, D. Gershman, A. Hilel, A. Ezra, S. Springer, T. Gurevich (Tel Aviv, Israel)

    Objective: To evaluate the feasibility of home-based transcranial direct current stimulation (tDCS) for people with cerebellar ataxia (CA). Background: tDCS induces non-invasive cortical plasticity via…
  • 2022 International Congress

    Exploring the diversity of alleviating manoeuvres in Cervical Dystonia

    L. Avanzino, F. Di Biasio, G. Bonassi, E. Pelosin, N. Cothros, R. Marchese, D. Martino (Genoa, Italy)

    Objective: We explored five different categories of alleviating manoeuvres (AMs) in patients with cervical dystonia (CD): pure sensory; sensorimotor manoeuvres in which sensory input is…
  • 2022 International Congress

    Differences in cognition and neuropsychiatric profiles between asymptomatic and symptomatic carriers of Huntington’s disease

    M. Turuelo (Barakaldo, Spain)

    Objective: To analyze cognitive and neuropsychiatric differences between asymptomatic and symptomatic carriers of Huntington's disease (HD) compared with healthy controls (HC) taking into account the…
  • 2022 International Congress

    Parkinson’s Disease, Cognition, Positive Symptoms and Medication Management

    O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, M. Buhse, M. Zarif, B. Anand, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between multi-domain cognitive testing and patient-reported psychiatric symptoms in PwPD to self-medication management capabilities. Background: Parkinson’s disease (PD) is a complex…
  • 2022 International Congress

    Cerebro-cerebellar motor networks in clinical subtypes of Parkinson’s disease

    F. Agosta, S. Basaia, A. Francia, C. Cividini, R. Balestrino, T. Stojkovic, I. Stankovic, V. Markovic, E. Sarasso, A. Gardoni, R. de Micco, L. Albano, E. Stefanova, VS. Kostic, M. Filippi (Milan, Italy)

    Objective: This study investigated functional alterations within the cerebro-cerebellar system in tremor-dominant (TD) and postural-instability-and-gait-disorder (PIGD) subtypes of Parkinson’s disease (PD) using stepwise functional connectivity…
  • 2022 International Congress

    Reduced Risk of Mortality and Antipsychotics in Parkinson’s Disease-Related Psychosis: Pimavanserin vs Off-Label Antipsychotics

    S. Isaacson, F. Pagan, D. Truong, V. Abler, R. Pahwa (Boca Raton, USA)

    Objective: Summarize the available data for the mortality risk associated with Parkinson’s disease (PD) psychosis (PDP) and pimavanserin. Background: PDP is associated with increased mortality…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley